RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ESPR
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Tuesday for Esperion Therapeutics
(Updated on Apr 30, 2024)

Sell candidate since Apr 11, 2024 Loss -14.72% PDF

The Esperion Therapeutics stock price fell by -1.01% on the last day (Tuesday, 30th Apr 2024) from $1.99 to $1.97. During the last trading day the stock fluctuated 4.90% from a day low at $1.94 to a day high of $2.04. The price has been going up and down for this period, and there has been a 3.14% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 2 million shares were bought and sold for approximately $4.59 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $1.79 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -10.49% during the next 3 months and, with a 90% probability hold a price between $1.60 and $2.81 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ESPR Signals & Forecast

A buy signal was issued from a pivot bottom point on Wednesday, April 17, 2024, and so far it has risen 7.07%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Esperion Therapeutics stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $2.00 and $2.32. A break-up above any of these levels will issue buy signals. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Esperion Therapeutics stock

Esperion Therapeutics finds support from accumulated volume at $1.95 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0950 between high and low, or 4.90%. For the last week, the stock has had daily average volatility of 6.36%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ESPR) For The Upcoming Trading Day Of Wednesday 1st

For the upcoming trading day on Wednesday, 1st we expect Esperion Therapeutics to open at $1.98, and during the day (based on 14 day Average True Range), to move between $1.75 and $2.19, which gives a possible trading interval of +/-$0.220 (+/-11.19%) up or down from last closing price. If Esperion Therapeutics takes out the full calculated possible swing range there will be an estimated 22.39% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.95 (1.02%) than the resistance at $2.07 (5.08%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Esperion Therapeutics will release earnings BMO on Tuesday, May 07, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.170. We will update the financials statements for Esperion Therapeutics, that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 12.19% in the first trading day after earnings release.

Is Esperion Therapeutics stock A Buy?

Esperion Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.414 Sell Candidate Unchanged

Predicted Opening Price for Esperion Therapeutics of Wednesday, May 1, 2024

Fair opening price May 1, 2024 Current price
$1.98 ( 0.592%) $1.97

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ESPR

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.08 5.41 %
R2 2.04 3.57 %
R1 2.02 2.43 %
Current price: 1.97
Support S1 1.95 -1.25 %
S2 1.92 -2.39 %
S3 1.89 -4.23 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.19 11.17 %
R2 2.14 8.63 %
R1 2.07 5.08 %
Current price 1.97
Support S1 1.95 -1.02%
S2 1.94 -1.78%
S3 1.91 -3.05%

FAQ

What is the symbol for Esperion Therapeutics Stock and on which exchange is it traded?
The symbol for Esperion Therapeutics is ESPR and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Esperion Therapeutics Stock?
Esperion Therapeutics holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Esperion Therapeutics Stock?
Esperion Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Esperion Therapeutics Stock.

What's the current price of Esperion Therapeutics Stock?
As of the end of day on the Apr 30, 2024, the price of an Esperion Therapeutics (ESPR) share was $1.97.

What is the 52-week high and low for Esperion Therapeutics Stock?
The 52-week high for Esperion Therapeutics Stock is $3.40 and the 52-week low is $0.700.

What is the market capitalization of Esperion Therapeutics Stock?
As of the Apr 30, 2024, the market capitalization of Esperion Therapeutics is 339.132M.

When is the next earnings date for Esperion Therapeutics?
The upcoming earnings date for Esperion Therapeutics is May 07, 2024.
Click to get the best stock tips daily for free!

About Esperion Therapeutics

Esperion Therapeutics Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration a... ESPR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT